Quetiapine-induced urinary retention
Ugeskrift for Læger · 2024
DOI: 10.61409/v04240243 ↗Kurz gefasst
Fallbericht in der Zeitschrift Ugeskrift for Læger, 2024. Verfasst von Stine Norup und 3 weiteren Autor:innen. Beteiligte Einrichtung: Aarhus Universitetshospital, Psykiatrien. Hauptthemen laut MEDLINE: Quetiapine Fumarate, Urinary Retention, Antipsychotic Agents.
Abstract (Originalsprache)
A 22-year-old woman, known to have a BMI of 12 kg/m2 and a personality disorder, developed urinary retention on a normal dose of quetiapine. She had earlier tolerated a dose of 800 mg quetiapine without complications. The daily dose was 600 mg in combination with oxazepam and zolpidem. Reduction had no effect. The patient intervened with intermittent urinary catheterization the next 19 months. Normal urinary function returned three days after the last dose of quetiapine 25 mg. This case report shows that patients with a low BMI may be more receptive of the anticholinergic effects of quetiapine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Aarhus Universitetshospital, Psykiatrien.
- Aarhus Universitetshospital, Klinisk Farmakologi.
Zitieren
APA
Norup, S., Rosenquist, S. B., Knudsen, T. R., & Thorgaard, M. V. (2024). Quetiapine-induced urinary retention. Ugeskrift for Læger. https://doi.org/10.61409/v04240243
Vancouver
Norup S, Rosenquist SB, Knudsen TR, Thorgaard MV. Quetiapine-induced urinary retention. Ugeskrift for Læger. 2024. doi:10.61409/v04240243
BibTeX
@article{Norup2024,
author = {Norup, Stine and Rosenquist, Sara Buttrup and Knudsen, Trine Reippuert and Thorgaard, Mette Viller},
title = {Quetiapine-induced urinary retention},
journal = {Ugeskrift for Læger},
year = {2024},
doi = {10.61409/v04240243}
}
EUVIMED